ProMetic Life Sciences Inc. – Product Pipeline Review – Q1 2011

Report Summary

Global M" />

Published : June 2011
No. of Pages : 51

Price:

Report Summary

Global Market Direct’s pharmaceuticals report, “ProMetic Life Sciences Inc. - Product Pipeline Review - Q1 2011” provides data on the ProMetic Life Sciences Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ProMetic Life Sciences Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from ProMetic Life Sciences Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

ProMetic Life Sciences Inc. - Brief ProMetic Life Sciences Inc. overview including business description, key information and facts, and its locations and subsidiaries.
Review of current pipeline of ProMetic Life Sciences Inc. human therapeutic division.
Overview of pipeline therapeutics across various therapy areas.
Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
Product profiles for late stage and clinical stage products of ProMetic Life Sciences Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
Recent updates of the ProMetic Life Sciences Inc.’s pipeline in the last quarter.
Key discontinued and dormant projects.
Latest news and deals relating to the products.

Reasons to buy

Evaluate ProMetic Life Sciences Inc.’s strategic position with total access to detailed information on its product pipeline.
Assess the growth potential of ProMetic Life Sciences Inc. in its therapy areas of focus.
Identify new drug targets and therapeutic classes in the ProMetic Life Sciences Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
Exploit collaboration and partnership opportunities with ProMetic Life Sciences Inc..
Avoid Intellectual Property Rights related issues.
Explore the dormant and discontinued projects of ProMetic Life Sciences Inc. and identify potential opportunities in those areas.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4
ProMetic Life Sciences Inc. Snapshot 5
ProMetic Life Sciences Inc. Overview 5
Key Information 5
Key Facts 5
ProMetic Life Sciences Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
ProMetic Life Sciences Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
ProMetic Life Sciences Inc. – Pipeline Products Glance 12
ProMetic Life Sciences Inc. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
ProMetic Life Sciences Inc.–Early Stage Pipeline Products 14
Pre-Clinical Products/Combination Treatment Modalities 14
ProMetic Life Sciences Inc. – Drug Profiles 15
PBI-1393 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
PBI-1402 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
PBI-0110 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
PBI-0110 + Gemcitabine 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
PBI-1522 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
PBI-1607 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
PBI-1668 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
PBI-1737 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
PBI-4050 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
PBI-4419 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
PBI-4494 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
ProMetic Life Sciences Inc. – Pipeline Analysis 26
ProMetic Life Sciences Inc. – Pipeline Products by Therapeutic Class 26
ProMetic Life Sciences Inc. - Pipeline Products By Target 28
ProMetic Life Sciences Inc. – Pipeline Products by Route of Administration 29
ProMetic Life Sciences Inc. – Pipeline Products by Molecule Type 30
ProMetic Life Sciences Inc. – Recent Pipeline Updates 31
ProMetic Life Sciences Inc. - Dormant Projects 32
ProMetic Life Sciences Inc. – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Financial Deals Landscape 35
ProMetic Life Sciences Inc., Deals Volume Summary, 2004 to YTD 2011 35
ProMetic Life Sciences Inc., Deals Summary By Region, 2004 to YTD 2011 36
ProMetic Life Sciences Inc., Deals Summary, 2004 to YTD 2011 37
ProMetic Life Sciences Inc. Detailed Deal Summary 38
Acquisition 38
ProMetic Life Sciences Acquires Additional 51% Stake In Pathogen Removal And Diagnostic Technologies From American Red Cross 38
Equity Offering 40
ProMetic Completes Private Placement Of $7 Million 40
ProMetic Life Sciences Completes Private Placement Of $7.9 Million 42
Novozymes Enters Into Co-Marketing Agreement With ProMetic Life Sciences 44
ProMetic Life Sciences Enters Into Co-Development Agreement With Abraxis BioScience 45
ProMetic Life Sciences Signs Co-Development Agreement With Octapharma 46
Licensing Agreements 47
Abraxis Enters Into License Agreement With ProMetic Life Sciences 47
Nabi Biopharmaceuticals Enters Into Agreement With ProMetic Life Sciences 49

Appendix 50
Methodology 50
Coverage 50
Secondary Research 50
Primary Research 50
Expert Panel Validation 51
Contact Us 51
Disclaimer 51

List of Tables

ProMetic Life Sciences Inc. - Pipeline by Therapy Area and Indication, 2011
ProMetic Life Sciences Inc. - Pipeline by Stage of Development, 2011
ProMetic Life Sciences Inc. - Monotherapy Products in Pipeline, 2011
ProMetic Life Sciences Inc. - Combination Treatment Modalities in Pipeline, 2011
ProMetic Life Sciences Inc. - Phase II, 2011
ProMetic Life Sciences Inc. - Phase I, 2011
ProMetic Life Sciences Inc. - Pipeline By Therapeutic Class, 2011
ProMetic Life Sciences Inc. - Pipeline By Target, 2011
ProMetic Life Sciences Inc. - Pipeline By Route of Administration, 2011
ProMetic Life Sciences Inc. - Pipeline By Molecule Type, 2011
ProMetic Life Sciences Inc. - Recent Pipeline Updates, 2011
ProMetic Life Sciences Inc. - Dormant Developmental Projects, 2010
ProMetic Life Sciences Inc., Other Locations
ProMetic Life Sciences Inc., Subsidiaries
ProMetic Life Sciences Inc., Deals Summary, 2004 to YTD 2011
ProMetic Life Sciences Inc., Deals Summary by Region, 2004 to YTD 2011
ProMetic Life Sciences Inc., Deals Summary, 2004 to YTD 2011

List of Figures

ProMetic Life Sciences Inc. – Product Pipeline Review – Q1 2011

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: